NCT05368298进行中（未招募）不适用
Sample Collection for The Integration and Analysis of Data Using Artificial Intelligence to Improve Patient Outcomes With Thoracic Diseases
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 872
- 试验地点
- 22
- 主要终点
- To develop an algorithm that gives a greater than chance improved ability to diagnose lung cancer using the blood biomarkers with or without the AI CT algorithm compared to not using them
研究概览
简要总结
The study will use a blood sample collected from participants to:
- Develop new ways of finding and diagnosing lung health problems, such as lung cancer.
- Develop tools which make it easier to screen people with possible lung health problems, diagnose problems earlier and with fewer tests, and start the best treatment faster.
- Help improve the early diagnosis of lung cancer, as finding lung cancer early means that it can be treated more easily and successfully.
详细描述
The results from this study will be linked with the data from the DART study (also collecting data through the Lung Health Check programme) to develop new ways of using computer technology (artificial intelligence) to improve lung health care. The studies use computer programs (called 'algorithms') which can be trained to analyse medical samples. Once developed, these algorithms can be used to support doctors by increasing their speed and accuracy of diagnosing issues.
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Other
入排标准
- 年龄范围
- 55 Years 至 75 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patient suitability will be assessed against the below criteria by the clinical teams managing the patients.
- •Inclusion Criteria:
- •Patients with a pulmonary nodule or nodule(s) detected on a CT scan performed as part of Lung Cancer Screening from the Lung Health Check centres, that require further investigation with a PET-CT scan, and / or biopsy, and / or resection
- •Willing and able to give informed consent
排除标准
- 未提供
结局指标
主要结局
To develop an algorithm that gives a greater than chance improved ability to diagnose lung cancer using the blood biomarkers with or without the AI CT algorithm compared to not using them
时间窗: by February 2025
次要结局
- To develop an algorithm that gives a greater than chance improved ability to diagnose lung cancer using the blood biomarkers with or without the AI CT and blood markers algorithm compared to not using them(by February 2025)
研究者
研究点 (22)
Loading locations...
相似试验
Enrolling By Invitation
不适用
Collection of Tissue Specimens From Patients With Solid Tumors or Blood Disorders and Their HLA-Compatible Family MembersNeoplasmsHematologic NeoplasmsHealthy VolunteersNCT00071045National Heart, Lung, and Blood Institute (NHLBI)6,000
已完成
不适用
Survey and Blood Sample Collection for Patients With Lung Cancer Who Never Smoked CigarettesLung CancerNCT00745160Memorial Sloan Kettering Cancer Center115
招募中
不适用
Samples From Human Subjects to Facilitate Basic, Translational and Clinical ResearchEndothelial DysfunctionInflammation in Cardiopulmonary and Vascular Disease StatesHealthy VolunteersNCT03253705National Institutes of Health Clinical Center (CC)1,000
招募中
不适用
A Clinicobiological Database in Metastatic Digestive CancersDigestive System NeoplasmNCT03978078Institut du Cancer de Montpellier - Val d'Aurelle200
已完成
不适用
Collection of Blood Specimens From Patients in AL-3789 Studies for Elevated Intraocular Pressure (IOP)Open-Angle GlaucomaNCT00691639Alcon Research1,000